Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-13 @ 7:55 AM
Study NCT ID:
NCT02781558
Status:
COMPLETED
Last Update Posted:
2018-11-27
First Post:
2016-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-20
First Submit QC Date:
None
Study First Post Date:
2016-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-04
Results First Submit QC Date:
None
Results First Post Date:
2018-10-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-30
Last Update Post Date:
2018-11-27
Last Update Post Date Type:
ACTUAL